Drug Type Chemical drugs |
Synonyms XHL-31 |
Target |
Mechanism EGFR C797S inhibitors(Epidermal Growth Factor Receptor C797S inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | CN | 15 Jan 2021 |